Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Urology. 2014 Feb 12;83(4):774–780. doi: 10.1016/j.urology.2013.10.073

Table 2.

Tumor and treatment characteristics of RCC patients by receipt of renal mass biopsy.

Characteristic RMB + RMB − χ2 P value
Tumor Size (cm):
 No mass 3 (0.1) 7 (0.0) P<0.0001
 ≤ 4 1,673 (32.7) 6,235 (31.8)
 4 – 7 1,452 (28.4) 6,297 (32.1)
 7 – 10 917 (17.9) 3,766 (19.2)
 ≥ 10 437 (8.6) 1,694 (8.7)
 Unknown 630 (12.3) 1,591 (8.1)
Tumor Stage:
 Localized 2,804 (54.9) 12,318 (62.9) P<0.0001
 Regional 802 (15.7) 3,842 (19.6)
 Distant 1,506 (29.5) 3,430 (17.5)
Treatment Type:
 Surgery 3,192 (62.4) 14,489 (74.0) P<0.0001
 Systemic Therapy 201 (3.9) 198 (1.0)
 Systemic Therapy + Surgery 155 (3.0) 355 (1.8)
 None 1,564 (30.6) 4,548 (23.2)
Surgical Type:
 Radical nephrectomy 2,702 (52.9) 12,964 (66.2) P<0.0001
 Partial nephrectomy 452 (8.8) 1,759 (9.0)
 Ablation 193 (3.8) 121 (0.6)
 None 1,765 (34.5) 4,746 (24.2)